Cyclobenzaprine Hydrochloride

Drug Usage Statistics, United States, 2004 - 2014

Number of Prescriptions Over Time (2004 - 2014)

Rank of Top Drugs Over Time

"Rank" refers to the frequency that a given medication is prescribed within a calendar year compared to all other medications. A rank of "4" would indicate that the medication was the fourth most commonly prescribed medication.

Year Rank Change
2004 71 -
2005 66  5
2006 69  3
2007 60  9
2008 58  2
2009 51  7
Year Rank Change
2010 39  12
2011 45  6
2012 45 0
2013 43  2
2014 43 0

Patient Out-Of-Pocket Cost Over Time (2004 - 2014)

"Out-of-pocket" cost refers to the payment made by the patient (either cash price or the copay amount). This value does not include reimbursement from a third party payer (eg, Medicare or private insurance) and does not represent the total drug cost.

Usage Statistics of Related Drugs

Drug Name Total Prescriptions (2014)
Cyclobenzaprine Hydrochloride (this drug) 20,610,429
Methocarbamol 5,908,996
Carisoprodol 4,459,908
Orphenadrine 991,046

Drug Synonyms

Drug synonyms are used during the sanitation and standardization process of "cleaning" the original data source (MEPS). Occassionally, brand names may be listed below that are no longer on the market or are very infrequently used.

Brand Name Synonyms
  • Amrix
  • Flexeril
Generic Drug Synonyms and Salts
  • Cyclobenzaprine Hydrochloride

FDA Approval Information

Established Pharmacologic Class (EPC): Muscle Relaxant
Initial FDA approval date: Prior to January 1, 1982
First FDA applicant: Janssen Research And Development Llc
First dosage form: Tablet (oral)

Prescription data source: Medical Expenditure Panel Survey (MEPS) 2004-2014. Agency for Healthcare Research and Quality (AHRQ), Rockville, MD. ClinCalc DrugStats Database version 17.0. Read more about the ClinCalc DrugStats database.


Related Links

Follow Us!

New and Popular


Open Menu

Cite This Page

Show AMA citation

Which of these drugs causes acute kidney injury? The Top 250 Drugs by ClinCalc Academy
©2018 - ClinCalc LLC. All rights reserved.
Disclaimer - Privacy Policy - Contact Us
Updated Mar 4, 2017
Back to Top